February 12, 2016
GMHC Expands HIV/STI Testing to Saturdays
EDGE READ TIME: 2 MIN.
Gay Men's Health Crisis (GMHC) will now offer free HIV and STI testing on Saturdays at the David Geffen testing center in Chelsea thanks to the generous support from the Calamus Foundation. Beginning on Saturday, February 13, the GMHC testing center will open its doors from 9 a.m. - 2 p.m. every Saturday for walk-in testing. Anyone interested in receiving a test should arrive no later than 1:45 p.m.
"New York has embarked on an ambitious goal to end the epidemic by 2020, and a key step in achieving this goal is increasing access to HIV testing," said GMHC CEO Kelsey Louie. "We can only end the epidemic if people are aware of their status, and have access to the latest testing technology. The Calamus Foundation has made a critical investment in helping New York end the epidemic, and I am very grateful for their leadership and continued partnership."
GMHC offers HIV Testing and STI Screening services to over 3,000 individuals yearly, and our testing center also offers linkage to care services and referrals for PrEP and PeP through partnership with Mount Sinai Hospital's Downtown Comprehensive Clinic.
At the Geffen Center, GMHC provides:
Gay Men's Health Crisis (GMHC) is the nation's leading provider of HIV and AIDS care, prevention services and advocacy, serving nearly 9,000 people living with and affected by HIV and AIDS in New York City, the epidemic's largest U.S. epicenter. As the world's first HIV and AIDS service organization, GMHC is an expert in providing services that every person affected by the epidemic deserves.
GMHC is on the front lines caring for people who are both HIV negative and positive, including: testing, nutrition, legal, mental health and education services. GMHC also advocates for stronger public policies at the local, state and federal level with the goal of ending AIDS as an epidemic in New York State by 2020. Most recently, GMHC and other HIV and AIDS organizations successfully persuaded the federal government to recommend widespread use of PrEP, a new daily treatment that is over 90 percent effective in preventing HIV infection.
For more information, visit www.gmhc.org.
